884 followers
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer https://t.co/PSc9G5OJKF
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer https://t.co/PSc9G5OJKF